Trial Profile
Study of the ability of 18F-MK6240, a second-generation selective tau tracer, to detect and measure global and regional tau burden in the brain
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Oct 2018
Price :
$35
*
At a glance
- Drugs Florquinitau F18 (Primary)
- Indications Alzheimer's disease; Neurodegenerative disorders
- Focus Diagnostic use
- 03 Oct 2018 New trial record